Cargando…

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Pers, Yves-Marie, Louis-Plence, Pascale, Portales, Pierre, Quentin, Julie, Fabre, Sylvie, Eliaou, Jean-François, Jorgensen, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242245/ http://dx.doi.org/10.1186/1479-5876-9-S2-P19

Ejemplares similares

Inducible Treg cell populations as cell based-therapy for rheumatoid arthritis
por: Martire, Delphine, et al.
Publicado: (2012)

Development of the automated immunomonitoring system
por: Osawa, Ryuji, et al.
Publicado: (2014)

Targeted delivery to inflammatory monocytes for efficient RNAi-mediated immuno-intervention in auto-immune arthritis
por: Présumey, Jessy, et al.
Publicado: (2011)

NAMPT/Visfatin expression by inflammatory monocytes mediates arthritis pathogenesis by promoting IL-17–producing T cells
por: Présumey, Jessy, et al.
Publicado: (2012)

In vitro immunomonitoring of insect venom-allergic patients on immunotherapy
por: Cifuentes, Liliana, et al.
Publicado: (2014)

Arthritis sensory and motor scale: predicting functional deficits from the clinical score in collagen-induced arthritis
por: Mausset-Bonnefont, Anne-Laure, et al.
Publicado: (2019)

From Immunomonitoring to Immune Intervention
por: Toubert, Antoine, et al.
Publicado: (2015)

Strategies for Immunomonitoring after Vaccination and during Infection
por: Adam, Lucille, et al.
Publicado: (2021)

Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
por: Duroux-Richard, Isabelle, et al.
Publicado: (2014)

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
por: Yamaguchi, Ken-ichi, et al.
Publicado: (2012)

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature
por: Spoerl, David, et al.
Publicado: (2012)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells
por: Pers, Yves-Marie, et al.
Publicado: (2018)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Immunomodulatory effect of unpulsed-immature dendritic cells in collagen-induced arthritis
por: Plence, PL, et al.
Publicado: (2005)

Tumor necrosis factor alpha reverses the immunosuppressive properties of mesenchymal stem cells in collagen-induced arthritis
por: Djouad, F, et al.
Publicado: (2005)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Post-transcriptional regulation of proinflammatory cytokines in arthritis using gene delivery of AU-rich element binding factors
por: Khoury, M, et al.
Publicado: (2005)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
por: Yilmaz, Sedat, et al.
Publicado: (2013)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014)

Tocilizumab-Induced Dermatosis in a Patient With Rheumatoid Arthritis
por: Babkoor, Doaa, et al.
Publicado: (2022)

X-Linked miRNAs Associated with Gender Differences in Rheumatoid Arthritis
por: Khalifa, Olfa, et al.
Publicado: (2016)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
por: Altwegg, Romain, et al.
Publicado: (2014)

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
por: Lazar, Katrin, et al.
Publicado: (2021)

Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring
por: Scheikl-Gatard, Tanja, et al.
Publicado: (2017)

Genetic markers in clinical subtypes of juvenile idiopathic arthritis
por: Le Blay, Pierre, et al.
Publicado: (2011)

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
por: Jones, Graeme, et al.
Publicado: (2010)

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
por: Al-Shakarchi, Israa, et al.
Publicado: (2013)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)

Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis
por: Anada, Mamiko, et al.
Publicado: (2020)

Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
por: Gualtierotti, Roberta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fasknep451qv9a6gukf62mi9eg